Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder
2004 · Journal of Psychiatric Research · 180 citations
https://doi.org/10.1016/j.jpsychires.2004.04.011
S
Stephen K. Brannan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
8.5K
Citations
33
h-index
43
i10-index
Stephen K. Brannan is an academic researcher from Bristol-Myers Squibb (Germany). The author has contributed to research in topics: Schizophrenia research and treatment & Treatment of Major Depression & Receptor Mechanisms and Signaling. The author has an h-index of 33, co-authored 85 publications.
ORCID: 0000-0003-0922-5970Papers by this author
worksSexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder
2005 · The Journal of Clinical Psychiatry · 134 citations
https://doi.org/10.4088/jcp.v66n0603
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia
2022 · Schizophrenia · 62 citations
https://doi.org/10.1038/s41537-022-00320-1
Making clinicians lives easier: Guidance on use of the QIDS self-report in place of the MADRS
2006 · Journal of Affective Disorders · 39 citations
https://doi.org/10.1016/j.jad.2006.03.024
Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial
2005 · Biological Psychiatry · 35 citations
https://doi.org/10.1016/j.biopsych.2005.05.025
Site-independent confirmation of primary site-based PANSS ratings in a schizophrenia trial
2021 · Journal of Psychiatric Research · 8 citations
https://doi.org/10.1016/j.jpsychires.2021.10.027
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat